Apimeds Pharmaceuticals US Inc (APUS)

$1.80 +0.05 (2.86%)
Market Cap 20.26M
Revenue (ttm) 0.00
Net Income (ttm) -1.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 72,072
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 11.58M
Stochastic %K 56%
Beta N/A
Analysts Strong Buy
Price Target N/A

Latest News on APUS

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

May 12, 2025, 5:14 PM EDT - 21 days ago

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading

May 10, 2025, 12:15 AM EDT - 24 days ago

U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading

AHL AII ANTA ETOR

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

May 8, 2025, 5:00 PM EDT - 25 days ago

Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering

Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO

Sep 25, 2024, 4:54 PM EDT - 8 months ago

Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO

Apimeds Pharmaceuticals US IPO Registration Document (S-1)

Sep 25, 2024, 3:14 PM EDT - 8 months ago

Apimeds Pharmaceuticals US IPO Registration Document (S-1)